...
首页> 外文期刊>European review for medical and pharmacological sciences. >Short term effect of a single dose of formoterol or tiotropium on the isolated nocturnal hypoxemia in stable COPD patients: a double blind randomized study.
【24h】

Short term effect of a single dose of formoterol or tiotropium on the isolated nocturnal hypoxemia in stable COPD patients: a double blind randomized study.

机译:单剂量福莫特罗或噻托溴铵对稳定型COPD患者孤立的夜间低氧血症的短期影响:一项双盲随机研究。

获取原文
获取原文并翻译 | 示例
           

摘要

Patients with stable chronic obstructive pulmonary disease (COPD) and diurnal PaO2 60 mmHg may have transient oxygen desaturation during sleep. The effect of bronchodilators on nocturnal hypoxemia is not known. The aim of this study was to evaluate if a single dose of Formoterol or Tiotropium, administered in the evening, could improve nocturnal hypoxemia in patients with stable middle/severe COPD. Thirty-seven patients (25 M/12 F; mean age 68.97 +/- 8.57, range 50-78; mean FEV1% of predicted 46.29 +/- 9.2) with PaO2 60 mmHg, but with significant oxygen desaturation during sleep and apnea/hypopnea index or = 10 were selected. They randomly underwent three consecutive nocturnal pulsoxymetry: baseline and after taking placebo and 12 microg of Formoterol (20 pts) or 18 microg of Tiotropium (17 pts) in the evening. FEV1 and IC, measured after 1 h of taking bronchodilators, were significantly higher than placebo. The variation, with regards to baseline values, in mean heart rate and Lowest SpO2% measured after Tiotropium (-1.68 +/- 4.01 and 3.23 +/- 8.58 respectively) was higher (p 0.05) than placebo (-0.108 +/- 2.85 and 0.29 +/- 7.05 respectively). Moreover, the trend time of SpO2% (measured by pulse-oximeter at each hour of total time registration) after Tiotropium was significantly higher than baseline or placebo (p 0.01). Instead, the trend time of SpO2% after Formoterol, except for an initial transient hypoxemia fall, was similar to baseline condition and after placebo. Also the trend time of heart rate resulted significantly lower in the Tiotropium group, but higher in the Formoterol group. In conclusion, Formoterol does not seem to influence the nocturnal hypoxemia in stable COPD patients probably for the worsening V/Q ratio. On the contrary, a single dose of tiotropium seems to decrease the severity in the nocturnal desaturations in stable COPD patients probably due to the reduction in the nocturnal bronchial colinergic tone.
机译:患有稳定的慢性阻塞性肺疾病(COPD)且昼夜PaO2> 60 mmHg的患者在睡眠期间可能会出现短暂的氧饱和度下降。支气管扩张剂对夜间低氧血症的作用尚不清楚。这项研究的目的是评估晚上服用单剂量的福莫特罗或噻托溴铵是否可以改善稳定/中度/重度COPD患者的夜间低氧血症。三十七例患者(25 M / 12 F;平均年龄68.97 +/- 8.57,范围50-78;平均FEV1%为预计的46.29 +/- 9.2),PaO2> 60 mmHg,但在睡眠和呼吸暂停期间氧饱和度显着降低选择/呼吸不足指数<或= 10。他们随机进行了三个连续的夜间脉搏血氧饱和度测定:基线和晚上服用安慰剂和12微克福莫特罗(20分)或18微克噻托溴铵(17分)。服用支气管扩张药1小时后测得的FEV1和IC明显高于安慰剂。就基线值而言,噻托溴铵治疗后的平均心率和最低SpO2%的变化(分别为1.68 +/- 4.01和3.23 +/- 8.58)比安慰剂(-0.108 +/-)更高(p <0.05)分别为2.85和0.29 +/- 7.05)。此外,噻托溴铵后SpO2%的趋势时间(在总时间记录的每一小时通过脉搏血氧仪测量)显着高于基线或安慰剂(p <0.01)。相反,福莫特罗治疗后SpO2%的趋势时间,除了最初的短暂性低氧血症下降外,与基线情况和安慰剂治疗后相似。噻托溴铵组的心率趋势时间也显着降低,而福莫特罗组则更高。总而言之,福莫特罗似乎不影响稳定型COPD患者的夜间低氧血症,可能是由于V / Q比恶化。相反,稳定的COPD患者单剂量噻托溴铵似乎可以降低夜间去饱和的严重程度,这可能是由于夜间支气管大肠菌能降低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号